Correlation Between BioInvent International and Isofol Medical

Can any of the company-specific risk be diversified away by investing in both BioInvent International and Isofol Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioInvent International and Isofol Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioInvent International AB and Isofol Medical AB, you can compare the effects of market volatilities on BioInvent International and Isofol Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioInvent International with a short position of Isofol Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioInvent International and Isofol Medical.

Diversification Opportunities for BioInvent International and Isofol Medical

0.26

Correlation Coefficient

BioInvent International  Isofol Medical

Modest diversification

The 3 months correlation between BioInvent and Isofol is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding BioInvent International AB and Isofol Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Isofol Medical AB and BioInvent International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioInvent International AB are associated (or correlated) with Isofol Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Isofol Medical AB has no effect on the direction of BioInvent International i.e., BioInvent International and Isofol Medical go up and down completely randomly.

Pair Corralation between BioInvent International and Isofol Medical

Assuming the 90 days trading horizon BioInvent International AB is expected to generate 0.62 times more return on investment than Isofol Medical. However, BioInvent International AB is 1.61 times less risky than Isofol Medical. It trades about -0.08 of its potential returns per unit of risk. Isofol Medical AB is currently generating about -0.2 per unit of risk. If you would invest  4,325  in BioInvent International AB on September 23, 2024 and sell it today you would lose (435.00) from holding BioInvent International AB or give up 10.06% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

BioInvent International AB  vs.  Isofol Medical AB

BioInvent International

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BioInvent International AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Isofol Medical AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Isofol Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Isofol Medical is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with BioInvent International and Isofol Medical

The main advantage of trading using opposite BioInvent International and Isofol Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioInvent International position performs unexpectedly, Isofol Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Isofol Medical will offset losses from the drop in Isofol Medical's long position.

The idea behind BioInvent International AB and Isofol Medical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.